During the past decade, Charité - Universitätsmedizin Berlin Institute of Allergology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Charité - Universitätsmedizin Berlin Institute of Allergology" are "Chronic Cold Urticaria" (1 trials), "Indolent Systemic Mastocytosis" (1 trials) and "Monoclonal Mast Cell Activation Syndrome" (1 trials). Many other conditions were trialed in "Charité - Universitätsmedizin Berlin Institute of Allergology" in a lesser frequency.

Most popular intervention types in "Charité - Universitätsmedizin Berlin Institute of Allergology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BLU-263" (1 trials), "Placebo" (1 trials) and "THB001" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charité - Universitätsmedizin Berlin Institute of Allergology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Charité - Universitätsmedizin Berlin Institute of Allergology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Charité - Universitätsmedizin Berlin Institute of Allergology, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Charité - Universitätsmedizin Berlin Institute of Allergology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".